4//SEC Filing
Banard Charlene A. 4
Accession 0001140361-23-010104
CIK 0001604464other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:16 PM ET
Size
7.0 KB
Accession
0001140361-23-010104
Insider Transaction Report
Form 4
Banard Charlene A.
EVP, Chief Technical Officer
Transactions
- Award
Common Stock
2023-03-01+139,700→ 295,050 total - Award
Employee Stock Option (Right to Buy)
2023-03-01+314,325→ 314,325 totalExercise: $3.91Exp: 2033-02-28→ Common Stock (314,325 underlying)
Footnotes (2)
- [F1]These restricted stock units vest in 12 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2023, subject to the reporting person's continuous service. "Company Quarterly Vesting Date" means March 1, May 15, August 15 and November 15 of each year.
- [F2]1/36th of the shares subject to the stock option vest and become exercisable each month, with the initial installment vesting on April 1, 2023, subject to the reporting person's continuous service.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001919506
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:16 PM ET
- Size
- 7.0 KB